Based on product, the HIV diagnosis market is categorized into consumables, software & services, and instruments. Out of these, during the historical period (2013–2016), consumables dominated the market, and these are predicted to continue dominating it during the forecast period. This is attributed to the surging cost of the reagents used during HIV tests and the advent of various innovative products in the market. The consumables are further bifurcated into assays, kits & reagents, and others.
Download Report Sample at:
The growing prevalence of the disease is predicted to boost the demand for diagnosis products, which, in turn, would result in the growth of the HIV diagnosis market. HIV easily spreads through a used needle or transfusion of infected blood to a healthy person. In the past few years, many low and middle-income as well as developing nations have witnessed an increase in the healthcare expenditure for the purpose of reducing the incidence of HIV.
Hence, the growing incidence of HIV/AIDS and significant healthcare expenditure on diagnosis and related activities are being witnessed as the major growth drivers of the market.
About P&S Intelligence
P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Toll-free: +1-888-778-7886 (USA/Canada)
Email: [email protected]
This post was originally published on Crypto Coin Guardian